These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


146 related items for PubMed ID: 2950673

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Effects of a novel platelet nitric oxide donor (LA816), aspirin, clopidogrel, and combined therapy in inhibiting flow- and lesion-dependent thrombosis in the porcine ex vivo model.
    Vilahur G, Segalés E, Salas E, Badimon L.
    Circulation; 2004 Sep 21; 110(12):1686-93. PubMed ID: 15381660
    [Abstract] [Full Text] [Related]

  • 24. The use of antithrombotic drugs in older people.
    Tufano A, Cerbone AM, Di Minno G.
    Minerva Med; 2002 Feb 21; 93(1):13-26. PubMed ID: 11850611
    [Abstract] [Full Text] [Related]

  • 25. Rationale for low-molecular weight heparin in coronary stenting.
    Zidar JP.
    Am Heart J; 1997 Nov 21; 134(5 Pt 2):S81-7. PubMed ID: 9396639
    [Abstract] [Full Text] [Related]

  • 26. Mechanisms of reocclusion after coronary thrombolysis.
    Eisenberg PR.
    Z Kardiol; 1993 Nov 21; 82 Suppl 2():175-8. PubMed ID: 8328198
    [Abstract] [Full Text] [Related]

  • 27. Sildenafil improves coronary artery patency in a canine model of platelet-mediated cyclic coronary occlusion after thrombolysis.
    Lewis GD, Witzke C, Colon-Hernandez P, Guerrero JL, Bloch KD, Semigran MJ.
    J Am Coll Cardiol; 2006 Apr 04; 47(7):1471-7. PubMed ID: 16580539
    [Abstract] [Full Text] [Related]

  • 28. [-New aspects in antithrombotic therapy--platelet inhibitors-].
    Terres W, Meinertz T.
    Herz; 1996 Feb 04; 21(1):1-11. PubMed ID: 8647575
    [Abstract] [Full Text] [Related]

  • 29. Recombinant full-length tissue factor pathway inhibitor (TFPI) prevents thrombus formation and rethrombosis after lysis in a rabbit model of jugular vein thrombosis.
    Kaiser B, Fareed J.
    Thromb Haemost; 1996 Oct 04; 76(4):615-20. PubMed ID: 8903005
    [Abstract] [Full Text] [Related]

  • 30. [The antithrombotic action of oral anticoagulants, acetylsalicylic acid (Aspirin) and dipyridamole (Persantin)].
    Loeliger EA.
    Ned Tijdschr Geneeskd; 1984 Oct 27; 128(43):2047-9. PubMed ID: 6390223
    [No Abstract] [Full Text] [Related]

  • 31. [Prevention and therapy with anticoagulants. Indications, experiences, results].
    Bruhn HD.
    Intensivmed Prax; 1979 Oct 27; (2):91-7. PubMed ID: 553881
    [No Abstract] [Full Text] [Related]

  • 32. Aspirin and dipyridamole in the prevention of acute coronary thrombosis complicating coronary angioplasty.
    Barnathan ES, Schwartz JS, Taylor L, Laskey WK, Kleaveland JP, Kussmaul WG, Hirshfeld JW.
    Circulation; 1987 Jul 27; 76(1):125-34. PubMed ID: 2954724
    [Abstract] [Full Text] [Related]

  • 33. Staged thrombolysis and percutaneous transluminal coronary angioplasty for unstable and postinfarction angina.
    Hurley DV, Bresnahan DR, Holmes DR.
    Cathet Cardiovasc Diagn; 1989 Oct 27; 18(2):67-72. PubMed ID: 2529036
    [Abstract] [Full Text] [Related]

  • 34. Antithrombotic therapy after myocardial reperfusion in acute myocardial infarction.
    Fuster V, Stein B, Badimon L, Chesebro JH.
    J Am Coll Cardiol; 1988 Dec 27; 12(6 Suppl A):78A-84A. PubMed ID: 3057038
    [Abstract] [Full Text] [Related]

  • 35. Prevention of restenosis after coronary angioplasty: a pharmacological approach.
    Meier B.
    Eur Heart J; 1989 Dec 27; 10 Suppl G():64-8. PubMed ID: 2697565
    [Abstract] [Full Text] [Related]

  • 36. Antithrombotic therapy for deep arterial injury by angioplasty. Efficacy of common platelet inhibition compared with thrombin inhibition in pigs.
    Lam JY, Chesebro JH, Steele PM, Heras M, Webster MW, Badimon L, Fuster V.
    Circulation; 1991 Aug 27; 84(2):814-20. PubMed ID: 1830520
    [Abstract] [Full Text] [Related]

  • 37. [Anticoagulation therapy in myocardial infarction (author's transl)].
    Bucher HJ.
    Schweiz Rundsch Med Prax; 1975 Apr 08; 64(14):425-32. PubMed ID: 765994
    [No Abstract] [Full Text] [Related]

  • 38. Pharmacology of angioplasty and intravascular thrombolysis.
    Murray PD, Garnic JD, Bettmann MA.
    AJR Am J Roentgenol; 1982 Oct 08; 139(4):795-803. PubMed ID: 6181669
    [Abstract] [Full Text] [Related]

  • 39. Prevention and management of thrombotic complications during coronary interventions. Combination therapy with antithrombins, antiplatelets, and/or thrombolytics: risks and benefits.
    Neuhaus KL, Zeymer U.
    Eur Heart J; 1995 Nov 08; 16 Suppl L():63-7. PubMed ID: 8869021
    [Abstract] [Full Text] [Related]

  • 40. Platelet-inhibitor drugs before and after coronary artery bypass surgery and coronary angioplasty: the basis of their use, data from animal studies, clinical trial data, and current recommendations.
    Chesebro JH, Fuster V.
    Cardiology; 1986 Nov 08; 73(4-5):292-305. PubMed ID: 2944585
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.